Cargando…
SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis
BACKGROUND: In Belgium, COVID-19 epidemy began on February 4, 2020 with a peak on April 10, 2020. Patients with cystic fibrosis (CF) followed in the Cliniques universitaires Saint-Luc were rapidly isolated before the government lockdown. METHODS: After the peak of the epidemy, we measured anti-SARS-...
Autores principales: | Berardis, S., Verroken, A., Vetillart, A., Struyf, C., Gilbert, M., Gruson, D., Gohy, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418700/ https://www.ncbi.nlm.nih.gov/pubmed/32828701 http://dx.doi.org/10.1016/j.jcf.2020.08.005 |
Ejemplares similares
-
Vitamin D intoxication in patients with cystic fibrosis: report of a single-center cohort
por: Planté-Bordeneuve, Thomas, et al.
Publicado: (2021) -
SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
por: Alicandro, Gianfranco, et al.
Publicado: (2022) -
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
por: McClenaghan, Elliot, et al.
Publicado: (2020) -
The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network
por: Pearson, Kelsie, et al.
Publicado: (2021) -
SARS-CoV-2 seroprevalence among people living with HIV in Guinea–Bissau
por: Dutschke, A., et al.
Publicado: (2022)